从Euphorbia hirta L.中对潜在的抗腹成分进行生物活性引导的分离,以及分子对接评估
Junkai Wu1, Xiaomeng Zhang2, Liyang Guo2
1School of Pharmacy, Quanzhou Medical College, Quanzhou, China.
Frontiers in veterinary science
|September 13, 2024
概括
Euphorbia hirta表现出显著的抗腹作用,其传统使用证实了这一点. 关键化合物isoquercitrin和quercitrin被确定为负责这种活性,显示了天然腹治疗的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 民族植物学 民族植物学
- 自然产品化学 自然产品化学
背景情况:
- (Euphorbia hirta L.) (Euphorbiaceae) 是一种用于治疗腹的传统民间药物,特别是在中国.
- 这项研究调查了其抗腹性能的科学基础,并确定了活性成分.
研究的目的:
- 为了评估Euphorbia hirta提取物和分离化合物的抗腹活性.
- 确定负责观察到效应的特定生物活性成分.
主要方法:
- 在麻油诱导的腹小鼠模型中评估了抗腹活性.
- 进行了水性提取物的生物活性导向分化和化合物的分离.
- 用分子对接研究来比较分离化合物与洛佩拉米德的结合亲和力.
主要成果:
- 水性提取物及其乙烯酸分离物表现出显著的,剂量依赖的抗腹活性.
- 隔离了异基和基,并证实它们具有抗腹作用.
- 分子对接显示,异基和基具有与洛佩拉米德可比的结合亲和力.
结论:
- 欧比亚 (Euphorbia hirta) 具有显著的抗腹特性,支持其在传统医疗中使用.
- 异基和基被确定为主要的生物活性成分,负责抗腹活性.
- 这些发现表明Euphorbia hirta是潜在的天然治疗腹的药物.
更多相关视频
12:34Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
Published on: January 12, 2024
771
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
240
相关概念视频
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
187
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
187
Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
